Pharmafile Logo
Pharmafocus logo
Advanced Search

Mike Paling receives outstanding contribution award

January 28, 2011
Medical Communications Mike Paling, TBWA/Paling Walters, awards

Mike Paling, chief executive and chairman of TBWA\Paling Walters has received an award for Outstanding Contribution to Pharmaceutical Marketing for …

News

EMA road map to prioritise pharmacovigilance

January 28, 2011
Research and Development, Sales and Marketing EMA, European Medicines Agency, pharmacovigilance

The European Medicines Agency is to prioritise issues such as pharmacovigilance over the next five years, while also looking closely …

News

Mixed picture on postcode prescribing

January 28, 2011
Sales and Marketing NHS reforms, PCTs, SHAs, postcode prescribing

There are high levels of variation between Strategic Health Authorities and Primacy Care Trusts in the uptake of new drugs, …

News

Decision on osteoporosis drug Protelos unchanged, says NICE

January 27, 2011
Sales and Marketing NICE, Protelos, Servier, osteoporotic fractures, strontium ranelate

NICE has published updated final guidance on preventing osteoporotic fractures following a reconsideration of the use of Servier’s Protelos. The …

News

England isn’t the sick man of Europe

January 27, 2011
Kings Fund, NHS, NHS reform, king's fund

A leading health economist has questioned claims by the health secretary Andrew Lansley that England’s health is lagging behind other …

News
Pfizer France Twitter

Digital Pharma: Pfizer expands European Twitter use

January 27, 2011
Medical Communications Digital Pharma blog, Pfizer, Twitter

Pfizer has expanded its use of Twitter with its French operations becoming the latest of its European subsidiaries to join …

News

Bertil Lindmark joins Almirall as R&D head

January 27, 2011
Research and Development Almirall, Bertil Lindmark, appointment, research and development

Almirall has appointed Bertil Lindmark as executive director of R&D following the retirement of Dr Per-Olof Andersson. Bertil joins the …

Appointment

Lilly Oncology chief resigns

January 27, 2011
Research and Development, Sales and Marketing Eli Lilly, John Johnson, Lilly Oncology, appointment, lilly, research and development, sales and marketing

Lilly has an unexpected search on its hands for someone to lead its oncology business after John Johnson unexpectedly announced …

News

Novartis posts strong growth but warns of tough year ahead

January 27, 2011
Sales and Marketing 2010 pharma results, Novartis

Novartis has posted strong sales growth for the full year but its chief executive warns of ‘headwinds in 2011’ as …

News

Prime Minister uses online network to rally doctors around reforms

January 27, 2011
Sales and Marketing Doctors.net.uk, GPs, commissioning, david cameron, docotrs, prime minister

 Prime Minister David Cameron has made exclusive use of Doctors.net.uk, the UK’s largest network of medical professionals, to reinforce his …

News
Press release

NICE decides to back Abilify in schizophrenia

January 27, 2011
Sales and Marketing Abilify, BMS, Bristol-Myers Squibb, NICE, Otsuka, aripiprazole, schizophrenia

NICE has changed its mind over Bristol-Myers Squibb’s and Otsuka Pharmaceuticals Abilify, deciding to recommend the drug as a schizophrenia …

News

Double Helix Consulting expands

January 26, 2011
Sales and Marketing Clara Loveman, Double Helix, Dr Clive Whitcher, Dr Laurence Wild, appointment, sales and marketing

Double Helix Consulting has appointed three new executives to its growing global team – Clara Loveman, Dr Clive Whitcher and …

Appointment

The Evolving Role of European Regulatory Agencies

January 26, 2011
Research and Development Consultancy, regulatory affairs, regulatory agencies

The regulatory landscape can change in a very short period of time. Matthew Walker, Senior Regulatory Affairs Executive at TRAC …

Feature
Thought Leadership

Pharma-biotech partnerships: creative approaches to doing the deal

January 26, 2011
Research and Development Susan Aldridge, biotech, biotech partnerships, pharma partnering

Research and development partnerships between big pharma and the biotech sector are now a vital component in bringing new medicines …

Feature

Sanofi buys into cancer antibody research

January 26, 2011
Research and Development Cancer, Oxford Biotherapeutics, Sanofi, Sanofi-Aventis, antibody drug conjugate, cancer research

Sanofi-Aventis has bought a global licence to develop and commercialise one of Oxford BioTherapeutics’ (OBT) oncology programmes. For an undisclosed …

News

J&J posts negative growth as pharma sales stall

January 26, 2011
Sales and Marketing 2010 pharma results, J&J, JJ, Johnson and Johnson, Remicade, Risperdal Consta

Falling fourth quarter sales of Risperdal Consta and Remicade capped a year to forget for Johnson and Johnson. The company’s …

News

Dr Marie-Paule Richard joins AiCuris as CMO

January 26, 2011
Research and Development AiCuris, Dr Marie-Paule Richard, appointment, research and development

German clinical research company AiCuris has appointed Dr Marie-Paule Richard as chief medical officer. She has over 24 years of …

Appointment

Eisai sepsis drug fails in phase III

January 26, 2011
Research and Development, Sales and Marketing Eisai, eritoran, perampanel, sepsis

A new treatment for severe sepsis could be abandoned entirely after phase III results fell short. Eisai’s eritoran did not …

News

NHS competition will prevent postcode lottery, says Lansley

January 25, 2011
NHS, NHS reforms, postcode prescribing

The government has pledged that value-based competition in the NHS will create “the very opposite of the postcode lottery”, following …

News
Amgen HQ

Amgen signs $1 billion cancer biotech deal

January 25, 2011
Research and Development Amgen, BioVex, OncoVEXGM-CSF, cancer vaccine

Amgen is set to pay $1 billion for US biotech firm BioVex, in the process gaining access to its novel …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026